Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Adaptive Biotechnologies Corporation ADPT

Full chart Compare
Set alert

Price alert · ADPT

All alert types
26.71 USD +0.91 (+3.53%)

At closeNov 4, 2026, 4:41 PM EST

26.71 0.00 0.00%

After hours · Nov 4, 4:41 PM ET

25.19 Day range 26.88
12.00 52-week range 30.74
YTD
+64.47%
1 year
+57.86%

Financial health

Altman Z-Score

2.95 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -41.6×
FY 2017: -98.3×FY 2018: -91.6×FY 2019: -63.7×FY 2020: -55.8×FY 2021: -19.2×FY 2022: -7.6×FY 2023: -3.1×FY 2024: -5.6×FY 2025: -41.6×
FY 2017 5y median -7.6× FY 2025
P/S 8.9×
FY 2017: 111×FY 2018: 76.3×FY 2019: 43.7×FY 2020: 78.9×FY 2021: 25.5×FY 2022: 5.9×FY 2023: 4.2×FY 2024: 4.9×FY 2025: 8.9×
FY 2017 5y median 5.9× FY 2025
P/B 11.3×
FY 2017: -18.9×FY 2018: -16.5×FY 2019: 6.5×FY 2020: 10.4×FY 2021: 6.5×FY 2022: 2.3×FY 2023: 2.3×FY 2024: 4.4×FY 2025: 11.3×
FY 2017 5y median 4.4× FY 2025
P/FCF -50.3×
FY 2017: -114×FY 2018: -110×FY 2019: 19.2×FY 2020: -46.1×FY 2021: -15.5×FY 2022: -5.4×FY 2023: -4.2×FY 2024: -8.9×FY 2025: -50.3×
FY 2017 5y median -8.9× FY 2025
EV/EBITDA -89.6×
FY 2017: -125×FY 2018: -109×FY 2019: -51.8×FY 2020: -53.6×FY 2021: -20.2×FY 2022: -6.3×FY 2023: -3.9×FY 2024: -7.2×FY 2025: -89.6×
FY 2017 5y median -7.2× FY 2025
EV/Sales 9.7×
FY 2017: 123×FY 2018: 85.4×FY 2019: 43.0×FY 2020: 78.7×FY 2021: 25.3×FY 2022: 6.0×FY 2023: 4.4×FY 2024: 5.2×FY 2025: 9.7×
FY 2017 5y median 6.0× FY 2025
FCF Yield -2.0%
FY 2017: -0.9%FY 2018: -0.9%FY 2019: 5.2%FY 2020: -2.2%FY 2021: -6.5%FY 2022: -18.4%FY 2023: -23.6%FY 2024: -11.2%FY 2025: -2.0%
FY 2017 5y median -11.2% FY 2025

Profitability

Gross Margin 74.2%
FY 2017: 59.2%FY 2018: 64.7%FY 2019: 73.8%FY 2020: 77.1%FY 2021: 68.1%FY 2022: 68.7%FY 2023: 55.6%FY 2024: 59.7%FY 2025: 74.2%
FY 2017 5y median 68.1% FY 2025
Operating Margin -20.6%
FY 2017: -115.7%FY 2018: -89.4%FY 2019: -92.1%FY 2020: -155.3%FY 2021: -135.4%FY 2022: -108.0%FY 2023: -133.3%FY 2024: -90.8%FY 2025: -20.6%
FY 2017 5y median -108.0% FY 2025
Net Margin -21.5%
FY 2017: -111.4%FY 2018: -83.4%FY 2019: -80.6%FY 2020: -148.6%FY 2021: -134.3%FY 2022: -108.0%FY 2023: -132.3%FY 2024: -89.1%FY 2025: -21.5%
FY 2017 5y median -108.0% FY 2025
ROE -27.2%
FY 2017: 19.1%FY 2018: 18.0%FY 2019: -12.0%FY 2020: -19.7%FY 2021: -34.3%FY 2022: -43.1%FY 2023: -73.0%FY 2024: -78.7%FY 2025: -27.2%
FY 2017 5y median -43.1% FY 2025
ROIC -13.1%
FY 2017: -13.0%FY 2018: -16.1%FY 2019: -9.4%FY 2020: -15.1%FY 2021: -25.7%FY 2022: -26.5%FY 2023: -39.0%FY 2024: -36.0%FY 2025: -13.1%
FY 2017 5y median -26.5% FY 2025
ROA -11.6%
FY 2017: -11.8%FY 2018: -14.0%FY 2019: -7.5%FY 2020: -13.1%FY 2021: -22.4%FY 2022: -23.4%FY 2023: -34.1%FY 2024: -29.6%FY 2025: -11.6%
FY 2017 5y median -23.4% FY 2025

Growth (YoY)

Revenue 54.8%
FY 2017: 0.0%FY 2018: 44.8%FY 2019: 52.8%FY 2020: 15.6%FY 2021: 56.9%FY 2022: 20.1%FY 2023: -8.1%FY 2024: 5.1%FY 2025: 54.8%
FY 2017 FY 2025
Operating Income 64.9%
FY 2017: 0.0%FY 2018: -11.9%FY 2019: -57.6%FY 2020: -94.9%FY 2021: -36.7%FY 2022: 4.2%FY 2023: -13.4%FY 2024: 28.4%FY 2025: 64.9%
FY 2017 FY 2025
EPS (diluted) 63.9%
FY 2017: 0.0%FY 2018: -7.3%FY 2019: -6.8%FY 2020: -125.5%FY 2021: -37.7%FY 2022: 31.5%FY 2023: -56.0%FY 2024: 30.8%FY 2025: 63.9%
FY 2017 FY 2025
Free Cash Flow 50.5%
FY 2017: 0.0%FY 2018: -3.2%FY 2019: 603.4%FY 2020: -186.8%FY 2021: -51.0%FY 2022: 21.3%FY 2023: 16.6%FY 2024: 40.8%FY 2025: 50.5%
FY 2017 FY 2025

Financial Health

Current Ratio 3.3×
FY 2017: 9.8×FY 2018: 7.9×FY 2019: 7.8×FY 2020: 6.9×FY 2021: 3.5×FY 2022: 5.1×FY 2023: 4.7×FY 2024: 2.9×FY 2025: 3.3×
FY 2017 5y median 3.5× FY 2025
Quick Ratio 3.2×
FY 2017: 9.5×FY 2018: 7.6×FY 2019: 7.7×FY 2020: 6.8×FY 2021: 3.4×FY 2022: 5.0×FY 2023: 4.5×FY 2024: 2.8×FY 2025: 3.2×
FY 2017 5y median 3.4× FY 2025
Debt / Equity 1.3×
FY 2017: -2.5×FY 2018: -2.2×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.2×FY 2022: 0.2×FY 2023: 0.3×FY 2024: 0.4×FY 2025: 1.3×
FY 2017 5y median 0.3× FY 2025
Net Debt / EBITDA -7.0×
FY 2017: -12.6×FY 2018: -11.6×FY 2019: 0.8×FY 2020: 0.1×FY 2021: 0.1×FY 2022: -0.1×FY 2023: -0.2×FY 2024: -0.3×FY 2025: -7.0×
FY 2017 5y median -0.2× FY 2025
Interest Coverage -4.8×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -47.2×FY 2023: -16.5×FY 2024: -14.0×FY 2025: -4.8×
FY 2017 5y median -14.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31